Quality system survey
This article was originally published in The Gray Sheet
Many device firms' quality management systems fail to adequately address safety issues associated with increasingly complex global supply chains, according to a survey of device industry professionals presented at the AdvaMed 2009 conference Oct. 12-14 in Washington, D.C. The study, conducted by quality management and compliance solutions provider Sparta Systems, found that 45% of firms feel their current quality systems are insufficient to mitigate compliance, risk and safety issues associated with supply chain management. In addition, 60% of companies have not begun preparing for FDA's electronic Medical Device Reporting mandate, proposed in August, which would require e-submission of post-market adverse events
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.